BIOL

BIOLASE Inc.

Price

return (12m)

0.00%

p/e

-0.12

p/bv

-0.51

DIVIDEND YIELD

0.00%

BIOL price

BIOLASE

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BIOL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BIOL

Valuation

P/E

-0.12

Sector -2.35

Industry 2.47

P/BV

-0.51

Sector 2.15

Industry 2.34

P/Revenue (PSR)

0.05

Sector 1.96

Industry 0.83

EV/EBITDA

-1.54

Sector -22.97

Industry -5.28

EV/EBIT

-1.08

Sector -37.52

Industry -17.09

P/EBITDA

-0.15

Sector 0.40

Industry 1.58

P/EBIT

-0.13

Sector -1.95

Industry 3.85

P/Total Assets

0.07

Sector 1.17

Industry 0.93

P/Net Current Assets

-0.17

Sector -11.01

Industry -19.51

P/Working Capital

-0.24

Sector -4.59

Industry 4.77

EPS

-0.58

Sector -0.90

Industry -0.51

BVPS

-0.13

Sector 3.82

Industry 5.86

Efficiency

Gross Margin

33.01%

Sector 44.19%

Industry 32.42%

EBITDA Margin

-13.33%

Sector -328.62%

Industry -72.72%

EBIT Margin

-18.96%

Sector -193.32%

Industry -11.24%

Operating Margin

-35.86%

Sector -24.85%

Industry -6.78%

Net Profit Margins

-41.68%

Sector -28.95%

Industry -15.92%

Asset Turnover

0.38

Sector 0.12

Industry 0.22

Profitability

ROE

443.63%

Sector -35.44%

Industry -27.29%

ROA

-62.69%

Sector -29.00%

Industry -14.61%

ROIC

-55.62%

Sector -441.29%

Industry -111.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.71

Sector 1.86

Industry 1.14

Net Debt / EBITDA

-0.10

Sector -1.34

Industry -27.13

Net Debt / EBIT

-0.07

Sector -0.70

Industry 3.95

Net Debt / Equity

-0.03

Sector -0.35

Industry 0.14

Gross Debt / Equity

-0.03

Sector 0.16

Industry 0.51

Equity/Assets

-0.14

Sector 0.42

Industry 0.28

Liabilities/Assets

-0.14

Sector 0.46

Industry 0.47

Growth

5Y Revenue CAGR

3.30%

Sector -

Industry -

5Y Earnings CAGR

2.83%

Sector -

Industry -

Fundamentals BIOL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
BIOL	-0.12	-0.51	443.63%	0.00%	$2.22 M	-41.68%
ISRG	39.74	6.82	17.15%	0.00%	$124.72 B	28.45%
ABT	33.60	3.57	10.61%	2.33%	$182.28 B	11.65%
MDT	22.67	2.17	9.59%	3.35%	$108.83 B	13.20%
BSX	16.43	0.00	-%	0.00%	$67.50 B	19.57%
TMDX	14.97	5.21	34.80%	0.00%	$2.57 B	27.04%
IDXX	40.43	28.46	70.38%	0.00%	$44.28 B	24.63%
RMD	19.99	4.68	23.41%	1.15%	$30.37 B	27.44%
SYK	37.03	5.38	14.52%	1.08%	$123.56 B	13.21%
PHG	19.28	1.89	9.80%	3.88%	$24.98 B	6.30%
COHR	104.97	4.47	4.26%	0.00%	$49.22 B	7.10%
INMD	10.92	1.44	13.18%	0.00%	$952.25 M	23.27%
DXCM	31.70	12.09	38.14%	0.00%	$31.69 B	20.12%
EW	49.23	0.00	-%	0.00%	$49.47 B	15.43%
BDX	40.36	1.90	4.72%	2.29%	$45.94 B	5.33%
IMRA	64.74	1.13	1.74%	92.47%	$101.64 M	0.00%
BDXB	8.75	0.54	6.12%	0.00%	$13.76 B	8.36%
ALGN	28.99	2.83	9.77%	0.00%	$11.99 B	9.99%
ABMD	64.27	11.14	17.32%	0.00%	$17.15 B	24.84%
SNN	12.97	2.54	19.61%	2.46%	$13.45 B	8.66%
ZBH	23.79	1.43	6.00%	1.03%	$18.11 B	9.05%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BIOL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/24/2005	07/12/2005	114.84972458
Dividends	04/21/2005	05/09/2005	114.84972458
Dividends	02/08/2005	02/24/2005	114.84972458
Dividends	12/13/2004	12/29/2004	114.84972458
Dividends	10/11/2004	10/27/2004	114.84972458
Dividends	08/12/2004	08/30/2004	114.84972458

ABOUT BIOLASE

BIOLASE Inc.

Average Investor10 user rating

4.0 (1 people)

United States

39 years

Founded: 1987

1992

Time since IPO - 34 years

135

Employees

BIOLASE Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.22 million, with shareholders equity totaling $-4.33 million.

The company employs approximately 135 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, BIOLASE Inc. reported $46.09 million in revenue, generating net income of $-19.21 million.

Key financial metrics include a P/E ratio of -0.12, a price-to-book (P/B) ratio of -0.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIOL.

Market cap

$2.22 million

Net worth

$-4.33 million

$-4,330,000.00

Assets

$30.64 million

$30,640,000.00

Total Shares Outstanding

33.00 million

33,000,000

Average Daily Trading Volume

$530.68 Thousand

$530,684.12

Sector

Health

Industry

Medical Supplies and Equipment

BIOL

BIOL revenue and profits

Financial Results BIOL

DRAG THE FRAME TO SEE MORE DATA

BIOL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$95.40 50,16% (12M)

P/E

45.51

2.54%

ROE

3.78%

P/BV

1.72

CI - Cigna

$279.77 4,58% (12M)

P/E

10.87

2.18%

ROE

16.04%

P/BV

1.74

CNC - Centene

$65.66 156,57% (12M)

P/E

-5.98

0.00%

ROE

-22.51%

P/BV

1.35

HUM - Humana

$381.71 45,20% (12M)

P/E

34.70

0.96%

ROE

6.63%

P/BV

2.30

SNY - Sanofi

$43.48 --4,12% (12M)

P/E

6.98

4.12%

ROE

18.43%

P/BV

1.29

HCA - HCA Healthcare

$410.59 8,30% (12M)

P/E

12.92

0.75%

ROE

-213.15%

P/BV

-27.54

LLY - Eli Lilly

$1,175.66 86,66% (12M)

P/E

40.46

0.57%

ROE

81.02%

P/BV

32.78

NVS - Novartis

$156.04 36,14% (12M)

P/E

23.36

1.98%

ROE

30.41%

P/BV

7.11